GLUT1 transporter-facilitated solid lipid nanoparticles loaded with anti-cancer therapeutics for ovarian cancer targeting
-
Published:2023-04
Issue:
Volume:637
Page:122894
-
ISSN:0378-5173
-
Container-title:International Journal of Pharmaceutics
-
language:en
-
Short-container-title:International Journal of Pharmaceutics
Author:
Jagdale Saili, Narwade MahavirORCID, Sheikh Afsana, Md Shadab, Salve Rajesh, Gajbhiye Virendra, Kesharwani PrashantORCID, Gajbhiye Kavita R.
Subject
Pharmaceutical Science
Reference44 articles.
1. Dendrimers as prospective nanocarrier for targeted delivery against lung cancer;Arora;Eur. Polym. J.,2022 2. Aziz, A., Rehman, U., Sheikh, A., Abourehab, M.A.S., Kesharwani, P., 2022. Lipid-based nanocarrier mediated CRISPR/Cas9 delivery for cancer therapy. 10.1080/09205063.2022.2121592. 3. In Vivo Pharmacokinetic and Hemocompatible Evaluation of Lyophilization Induced Nifedipine Solid-Lipid Nanoparticle;Barman;Pharmacol. & Pharm.,2014 4. Formulation and Development of Transferrin Targeted Solid Lipid Nanoparticles for Breast Cancer Therapy;Bhagwat;Front. Pharmacol.,2020 5. Diniz, F., Coelho, P., Duarte, H.O., Sarmento, B., Reis, C.A., Gomes, J., 2022. Glycans as Targets for Drug Delivery in Cancer. Cancers, Vol. 14, Page 911 14, 911. 10.3390/CANCERS14040911.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|